M NE 17 (Nisoldipine Extended Release 17 mg)
Pill with imprint M NE 17 is Yellow, Round and has been identified as Nisoldipine extended release 17 mg. It is supplied by Mylan Pharmaceuticals Inc..
Nisoldipine is used in the treatment of raynaud's syndrome; angina pectoris prophylaxis; high blood pressure and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nisoldipine 17 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for M NE 17
Nisoldipine extended release
- Imprint:
- M NE 17
- Strength:
- 17 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Yellow No. 6
polydextrose
polyethylene glycol
titanium dioxide
triacetin
Note: Inactive ingredients may vary.
More about nisoldipine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: calcium channel blocking agents
Consumer resources
Other brands: Sular
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
